Circulating metabolic signatures of heart failure in precision cardiology
Authors:
Open Access
- 3 March 2023
- journal article
- review article
- Published by Oxford University Press (OUP) in Precision Clinical Medicine
- Vol. 6 (1) , pbad005
Abstract
Precision cardiology aims to implement personalized health care and precise medical decisions based on the specific characteristics of individuals. Metabolic remodeling plays a causal role in the pathogenesis of heart failure (HF). Changes in metabolic pathways such as substrate preference, high-energy phosphate metabolism and amino acid metabolism, are involved in pathological structural remodeling and functional impairment. These metabolic alterations are usually not restricted in the cardiac tissue, but also manifest in circulation. In clinical practice, blood sample is routinely used for HF screening. Metabolomics is an emerging omics technology that provides an efficient way to acquire dynamic metabolic profiles in circulation. An increasing number of metabolic biomarkers have been implicated in disease progression, making it possible to fight HF in a more effective and precise way. This review summarizes the modern analytical techniques in metabolomics as well as emerging circulating metabolites during the pathogenesis of HF, aiming to provide new insights into the prevention, diagnosis and treatment of HF in the era of precision medicine.Keywords
Funding Information
- National Natural Science Foundation of China (81970715)
- Key Research and Development Program of Sichuan Province (2022YFS0132)
- Sichuan University (2018SCUH0065)
This publication has 146 references indexed in Scilit:
- Plasma phospholipid saturated fatty acids and heart failure risk in the physicians' health studyClinical Nutrition, 2013
- Cardiac Metabolism in Heart FailureCirculation Research, 2013
- Plasma Phospholipid Concentration of Cis -Palmitoleic Acid and Risk of Heart FailureCirculation: Heart Failure, 2012
- Prognostic Usefulness of Free Fatty Acids in Patients With Stable Coronary Heart DiseaseThe American Journal of Cardiology, 2011
- Suppression of circulating free fatty acids with acipimox in chronic heart failure patients changes whole body metabolism but does not affect cardiac functionAmerican Journal of Physiology-Heart and Circulatory Physiology, 2010
- Oxygen consumption is depressed in patients with lactic acidosis due to biguanide intoxicationCritical Care, 2010
- Chronic Heart Failure: Contemporary Diagnosis and ManagementMayo Clinic Proceedings, 2010
- Glucose Control and Vascular Complications in Veterans with Type 2 DiabetesNew England Journal of Medicine, 2009
- Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trialThe Lancet, 2008
- An unexpected inverse relationship between HbA1c levels and mortality in patients with diabetes and advanced systolic heart failureAmerican Heart Journal, 2006